Actively Recruiting
Graftless TSFE Via Self-tapping Implants
Led by Sana'a University · Updated on 2026-02-20
20
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective clinical trial aims to evaluate the efficiency, safety, and reliability of a minimally invasive graftless transcrestal sinus lifting approach with simultaneous dental implant placement in patients with edentulous posterior maxilla and limited residual bone height. The study investigates bone formation beneath the Schneiderian membrane, implant stability, osseointegration, and long-term implant survival.
CONDITIONS
Official Title
Graftless TSFE Via Self-tapping Implants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18-80 years
- Patients with missing teeth in the back of the upper jaw
- Residual bone height approximately 4-6 mm
- Suitable for transcrestal sinus membrane elevation procedure
- Good general health (ASA I or II)
- Able to give written informed consent
- Willing to attend follow-up visits
You will not qualify if you...
- Severe systemic diseases (ASA III or above)
- Uncontrolled diabetes mellitus
- Active sinus disease
- History of radiotherapy in the head and neck area
- Heavy smokers (more than 10 cigarettes per day)
- Pregnancy or breastfeeding
- Untreated gum disease
- Poor oral hygiene
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Oral and Maxillofacial Surgery, Sana'a University
Sanaa, Sanaa Governorate, Yemen, 00000
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here